SAN DIEGO, CA - (BUSINESS WIRE) - Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, announced today the appointment of veteran biotech executive and Chairman of FibroGen, Inc., Jim Schoeneck, to its Board of Directors. Throughout his…
Calidi BiotherapeuticsJuly 1, 2020